Selected
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
2595 results found
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
  • Vaccine/vaccination
  • Adults
  • Older adults
  • Saudi Arabia
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Rating:
Critically low
2023 ∙ Segal, H. A. Rashid, N.
A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
Rating:
Not applicable
2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.
Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • All age groups
  • Healthcare workers
  • India
  • COVID-19
  • Acceptance
Rating:
Not applicable
2023 ∙ Derbie, A. Mekonnen, D. Misgan, E. Maier, M. Woldeamanuel, Y. Abebe, T.
Acceptance of human papillomavirus vaccination and parents’ willingness to vaccinate their adolescents in Ethiopia: a systematic review and meta-analysis
  • Parents/caregivers
  • Ethiopia
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Rating:
Not applicable
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
  • Economic aspects
Rating:
Not applicable
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Liatsou, E. Ntanasis-Stathopoulos, I. Lykos, S. Ntanasis-Stathopoulos, A. Gavriatopoulou, M. Psaltopoulou, T. Sergentanis, T. N. Terpos, E.
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Putri, E. A. C. Munir, M. Setiawan, H. K. Herawati, L. Sari, G. M. Wungu, C. D. K. Susilo, H. Sutanto, H.
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
  • Vaccine/vaccination
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Safety
Rating:
Critically low